Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Cardiothoracic Surgery, Dianjiang People's Hospital of Chongqing, Chongqing, China.
Proteins. 2019 Nov;87(11):979-991. doi: 10.1002/prot.25760. Epub 2019 Jun 28.
The TIM protein is a short isoform of full-length Rho guanine nucleotide exchange factor 5 (ARHGEF5), which acts as a functional regulator of Rho-dependent signaling pathways by activating the Rho family of GTPases. The activation is auto-inhibited by a putative helix N-terminal to the DH domain of TIM, which is stabilized by the intramolecular interaction of C-terminal SH3 domain with a proline-rich region SSPRQPRKAL (termed as SSP peptide) between the putative helix and the DH domain. Previously, we demonstrate that the auto-inhibitory state of TIM protein can be relieved by targeting its SH3 domain with rationally designed peptide ligands. However, the designed natural peptides have only a moderately increased affinity (~2-fold) as compared to the cognate SH3-SSP interaction and are susceptible to protease degradation. Here, considering that proline is the only endogenous N-substituted amino acid that plays a critical role in SH3-peptide recognition, the two key proline residues Pro49 and Pro52 in the core PxxP motif of SSP peptide are systematically replaced by 19 N-substituted amino acid types to derive a variety of nonnatural peptoid ligands for TIM SH3 domain. Dynamics and energetics analyses reveal that the replacement would impair the active polyproline II (PPII) helical conformation of SSP peptide due to lack of structural constraint introduced by the five-membered ring of native proline side-chains, thus increasing the peptide flexibility that could incur a large entropy penalty upon binding to the domain. However, the impairment is not very significant and the peptide affinity may also be restored and improved if the N-substituted motif of derived peptiod ligands can effectively interact with the PxxP-binding site of TIM SH3 domain. Consequently, a number of potent peptoids are successfully designed by fluorescence spectroscopy confirmation, in which three (ie, SSP[N-Ile49, N-Asn52], SSP[N-Phe49, N-Gln52], and SSP[N-Tyr49, N-Asn52]) exhibit considerably increased affinity (K = 0.09, 0.07, and 0.04 μM, respectively) relative to the native SSP peptide (K = 0.87 μM). In addition, guanine nucleotide exchange assays also substantiate that the designed SH3-targeted peptiods can effectively enhance TIM-catalyzed RhoA exchange activity (EA), which is observed to present an exponential relationship with the measured SH3-peptoid binding affinity (pK ).
TIM 蛋白是全长 Rho 鸟苷酸交换因子 5(ARHGEF5)的短同工型,通过激活 Rho 家族 GTP 酶,充当 Rho 依赖性信号通路的功能性调节剂。TIM 的 DH 结构域之前的假定螺旋通过分子内相互作用稳定,SH3 结构域与假定螺旋和 DH 结构域之间富含脯氨酸的区域 SSPRQPRKAL(称为 SSP 肽)的 C 端 SH3 结构域相互作用,从而使 TIM 蛋白自动抑制。此前,我们证明通过靶向其 SH3 结构域用合理设计的肽配体可以缓解 TIM 蛋白的自动抑制状态。然而,与同源 SH3-SSP 相互作用相比,设计的天然肽仅具有适度增加的亲和力(~2 倍),并且容易被蛋白酶降解。在这里,考虑到脯氨酸是唯一在 SH3-肽识别中起关键作用的内源性 N-取代氨基酸,因此,SSP 肽核心 PxxP 基序中的两个关键脯氨酸残基 Pro49 和 Pro52 被系统地替换为 19 种 N-取代氨基酸类型,以衍生出各种非天然类肽配体用于 TIM SH3 结构域。动力学和能量分析表明,由于缺乏天然脯氨酸侧链五元环引入的结构约束,取代会破坏 SSP 肽的活性多脯氨酸 II(PPII)螺旋构象,从而增加了与该结构域结合时可能产生大的熵罚的肽灵活性。然而,这种损伤并不非常显著,如果衍生的类肽配体的 N-取代基能够有效地与 TIM SH3 结构域的 PxxP 结合位点相互作用,那么肽亲和力也可能恢复和提高。因此,通过荧光光谱确认成功设计了许多有效的类肽,其中三种(即 SSP[N-Ile49,N-Asn52],SSP[N-Phe49,N-Gln52]和 SSP[N-Tyr49,N-Asn52])的亲和力(K = 0.09、0.07 和 0.04 μM,分别)与天然 SSP 肽(K = 0.87 μM)相比有明显提高。此外,鸟嘌呤核苷酸交换测定也证实,设计的 SH3 靶向类肽可以有效增强 TIM 催化的 RhoA 交换活性(EA),观察到与测量的 SH3-类肽结合亲和力(pK )呈指数关系。